Abstract: Embodiments of the present disclosure provide a membrane oxygenator including an upper cover, a lower cover, a shell, and an oxygenation structure. Both ends of the shell are connected with the upper cover and the lower cover respectively. The oxygenation structure includes a mandrel, an oxygen pressure membrane, and a temperature-changing membrane, wherein an upper end of the mandrel enters a first blood path space of the upper cover, a lower end of the mandrel is opposite to a blood outlet of the lower cover, the oxygen pressure membrane is provided around the mandrel and connects a first gas path space and a second gas path space, and the temperature-changing membrane wraps around the oxygen pressure membrane. A gap is provided between the temperature-changing membrane and an inner wall of the shell. A blood inlet is provided on the shell near the upper cover.

Abstract: A blood treatment air purging system and method includes a level detector positioned and arranged to detect a low fluid level in a blood circuit indicating a high amount of air in the blood circuit; a blood pump operable with the blood circuit; a venous patient line of the blood circuit; and at least one blood circuit air vent valve, wherein the system and method are configured or programmed to (i) stop the blood pump, (ii) close the venous patient line, and (iii) open the at least one blood circuit air vent valve to atmosphere or a container when the low fluid level is detected, and (iv) run the blood pump to meter air through the at least one blood circuit air vent valve to atmosphere or the container.

Abstract: Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.

Abstract: The invention provides a blood treatment device comprising: a dialyser; an inlet pump assembly; an outlet pump assembly; and a control system. The inlet pump assembly configured to deliver a first volume of dialysate from a dialysate source to the dialyser in an inlet pump cycle having a dialysate delivery stroke. The outlet pump assembly configured to remove a second volume of dialysate from the dialyser and deliver the dialysate away from the dialyser in an outlet pump cycle having a dialysate removal stroke. The control system is configured to operate the inlet pump assembly in the inlet pump cycle, and configured to operate the outlet pump assembly in the outlet pump cycle. For each inlet pump cycle there is a corresponding outlet pump cycle, and each inlet pump assembly dialysate delivery stroke has a commencement time t1 and a termination time h, and each outlet pump assembly dialysate removal stroke has a commencement time t3 and a termination time t4.

Abstract: The application relates to a hydrocephalus valve for draining CSF from the ventricle systems of patients. The valve has a housing with a housing interior and at least one first passage for admission and/or discharge. The valve has at least one body provided in the housing interior. The body is designed to move in at least one direction. At least one adjusting unit is provided. The application aims to improve tried-and-tested existing valves. To achieve this, the adjusting unit is designed to adjust at least one drainage rate in the passage, and to allow the drainage rate to be adjusted between 1 ml per hour and 1000 ml per hour at a pressure at the hydrocephalus valve of 20 cm water column, in order to slow or accelerate, by means of this adjustment, a change in pressure in the ventricle system that results from the drainage.

Abstract: Systems, catheters, and methods for accessing and treating along the central nervous system are disclosed. An example method may control operation of a pump of pump/filtration system to facilitate removing cerebrospinal fluid from a patient, filtering the cerebrospinal fluid with a filter module to remove waste product, and returning the filtered cerebrospinal fluid to the patient. Operation of the pump may be adjusted based on a value related to a measure sensed by a sensor in communication with a lumen carrying cerebrospinal fluid through the filtration system.

Abstract: Described are embodiments that include methods and devices for separating components from multi-component fluids. Embodiments may involve use of separation vessels and movement of components into and out of separation vessels through ports. Embodiments may involve the separation of plasma from whole blood. Also described are embodiments that include methods and devices for positioning portions, e.g., loops, of disposables in medical devices. Embodiments may involve use of surfaces for automatically guiding loops to position them into a predetermined position.

Abstract: The invention provides an apparatus for fecal management, comprising a device for collection of fecal discharge, and an insertion component. The device for collection of fecal discharge may comprise an expansile retaining component configured for deployment within a subject's rectum and having an annular cross-section. The insertion component may be configured for rectal insertion of the retaining component, and may include an elongate shaft having a first end positioned proximal to the retaining component and a second end positioned distal to the retaining component. At least one of the retaining component and the elongate shaft may be provided with a plurality of constraining members configured to releasably constrain the retaining component in a collapsed configuration against an external surface of the elongate shaft.

Abstract: The exemplary systems and methods may generate treatment records for extracorporeal blood treatments. The treatment records may include a plurality of values of various parameters. The various parameters may include a compulsory set of parameters that are preset, a dependent set of parameters that a dependent on one or more of a selected treatment and a system configuration, and a discretionary set of parameters that are selected by a user.

Abstract: In some examples, provided is a fluid blockage device for use with a reduced-pressure source for treating a tissue site with reduced pressure. The fluid blockage device may be configured to preclude fluid communication through a port fluidly coupled to the reduced-pressure source when the fluid blockage device contacts a liquid. Other devices, systems, and methods are disclosed.

Abstract: A method and system for performing transseptal extracorporeal membrane oxygenation is disclosed. The method may include puncturing a septum between the right atrium and the left atrium and advancing a catheter system through the puncture and into the aorta. A first portion of the catheter system can remove blood from the patient, in some examples near the inferior vena cava. A second portion can return oxygenated blood to the patient, through the transseptal puncture and into the aorta.

Abstract: A blood pump is disclosed. The blood pump apparatus is arranged to provide pulsatile flow, and comprises a flexible inner cylindrical duct providing a blood flow region, and an outer cylindrical duct arranged to surround the inner cylindrical duct and arranged to accommodate a pumping fluid. In the pump the inner cylindrical duct is described as comprising a blood inlet for receiving blood into the region, a blood outlet for passing blood out from the blood flow region and a passageway therebetween. There is also described the feature of the inner duct comprising a non return valve at the blood inlet and a non return valve at the blood outlet, the outer cylindrical duct having a fluid port for a pumping fluid, and a pump device arranged to cyclically deliver and withdraw pumping fluid to the fluid port thereby cyclically compressing and expanding the flexible inner cylindrical duct urging blood through the blood flow region and delivering a pulsating blood flow through the blood outlet.

Abstract: Systems and methods for implanting an endovascular shunt in a patient is disclosed. The system having an expandable anchor configured for being deployed in a dural venous sinus of a patient at a location distal to a curved portion of a wall of an inferior petrosal sinus (IPS) of the patient; an elongate guide member coupled to, and extending proximally from, the anchor; a shunt delivery catheter having a first lumen configured to receive the guide member, and a second lumen extending between respective proximal and distal openings in the shunt delivery catheter, the shunt delivery catheter further having a penetrating element coupled to a distal end of the catheter; and the system further having a guard at least partially disposed over, and movable relative to, the penetrating element.

Abstract: Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.

Abstract: A wound therapy device includes a wound dressing and a humidifier configured to deliver humid air to a wound site to which the wound dressing is applied. The humidifier may be a remote structure that is fluidly connected to the wound dressing applied about a patient's skin at a wound site. Alternatively, the humidified may be integrated with the wound dressing to define an integral, portable therapy device that may be worn by the patient. The wound therapy device may be a standalone wound treatment device, or may be used in conjunction with other wound treatment devices, such as, e.g., negative pressure wound therapy devices.

Abstract: The present invention provides a hollow fiber membrane oxygenator comprising a housing comprising a blood flow path; a blood inlet port and a blood outlet port disposed in the housing so as to allow blood to flow through the blood flow path; a gas exchange part comprising a bundle of a plurality of hollow fiber membranes disposed in the blood flow path, a gas inflow port and a gas outflow port provided in the housing so as to allow an oxygen-containing gas to flow through lumens of the hollow fiber membranes, and a gas temperature control part for adjusting the temperature of a gas flowing through the lumens of the hollow fiber membranes.

Abstract: A container for transporting and/or processing a biopharmaceutical fluid, the container comprising a wall, the wall comprising a shape memory material being adapted to change shape when induced by an external stimulus, so that the container can be alternately in a collapsed state and in an unfolded state, the wall of the container in the unfolded state delimiting an internal cavity adapted to contain the biopharmaceutical fluid.

Abstract: Described are embodiments that include methods and devices for separating components from multi-component fluids. Embodiments may involve use of separation vessels and movement of components into and out of separation vessels through ports. Embodiments may involve the separation of plasma from whole blood. Also described are embodiments that include methods and devices for positioning portions, e.g., loops, of disposables in medical devices. Embodiments may involve use of surfaces for automatically guiding loops to position them into a predetermined position.

Abstract: A monitor device and an ostomy system comprising a monitor device (6) and an ostomy appliance (2) is disclosed, the ostomy appliance including a base plate (4), the base plate having a first adhesive layer with a proximal side configured for attachment of the base plate to the skin surface of a user, the first adhesive layer having a stomal opening (18) with a center point, the monitor device comprising a processor and a sensor unit comprising a first sensor with a first sensor surface accommodated in a monitor device housing, the monitor device housing having a sensor opening in a proximal surface of the monitor device, the sensor opening forming at least a part of a sensor path from surroundings of the proximal surface to the first sensor surface.

Abstract: Methods and devices that prevent stasis in the LAA by either increasing the flow through the LAA or by closing off or sealing the LAA. Increasing the flow is accomplished through shunts, flow diverters, agitators, or by increasing the size of the ostium. Closing off the LAA is accomplished using seals or by cinching the LAA.